| Autoimmune Disorders | Focus: Autoimmune Disorders No. of deals: 112 No. of companies: 133 Years covered: 1996 – 2011 Price: € 700 ex VAT (if applicable) System requirements: Windows 2000 / XP / Vista / 7 |
|
|---|---|---|
| Cardiovascular Disorders | Focus: Cardiovascular Disorders No. of deals: 100 No. of companies: 107 Years covered: 1996 – 2011 Price: € 700 ex VAT (if applicable) System requirements: Windows 2000 / XP / Vista / 7 |
|
| CNS Disorders | Focus: CNS disorders
No. of deals: 206 No. of companies: 160 Years covered: 1996 – 2011 Price: € 800 ex VAT (if applicable) System requirements: Windows 2000 / XP / Vista / 7 |
|
| Infectious Diseases | Focus: Infectious Diseases
No. of deals: 185 No. of companies: 157 Years covered: 1996 – 2011 Price: € 800 ex VAT (if applicable) System requirements: Windows 2000 / XP / Vista / 7 |
|
| Metabolic Disorders | Focus: Metabolic Disorders
No. of deals: 118 No. of companies: 116 Years covered: 1996 – 2011 Price: € 700 ex VAT (if applicable) System requirements: Windows 2000 / XP / Vista / 7 |
|
| Oncology | Focus: Oncology
No. of deals: 319 No. of companies: 242 Years covered: 1996 – 2011 Price: € 975 ex VAT (if applicable) System requirements: Windows 2000 / XP / Vista / 7 |
| Research Alliances | Focus: Research Alliances
No. of deals: 340 No. of companies: 242 Years covered: 1996 – 2011 Price: € 975 ex VAT (if applicable) System requirements: Windows 2000 / XP / Vista / 7 |
|---|
| Therapeutic Antibodies | Focus: Therapeutic antibodies
No. of deals: 149 No. of companies: 150 Years covered: 1996 – 2011 Price: € 700 ex VAT (if applicable) System requirements: Windows 2000 / XP / Vista / 7 |
|---|
If you are looking for deal financials from specific licensees or on specific indications, compound classes, product development stages, in specific territories, within specific time frames or any other criteria of interest to you, please contact us. We are specialized in providing clients with financial deal information according to their specifications to support their product valutation and deal negotiations